Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of chlorhexidine and Periosciences antioxidant oral care products (such as AO ProVantage gel) is utilized as an adjunctive regimen in the treatment of periodontal diseases, including Stage II Grade B periodontitis, and for post-surgical oral care. Chlorhexidine is a cationic bisbiguanide antiseptic that provides broad-spectrum antimicrobial activity by disrupting bacterial cell membranes. Periosciences products utilize topically applied antioxidants, such as phloretin and ferulic acid, to neutralize free radicals, reduce oxidative stress, and downregulate inflammatory cytokines in oral tissues. Together, this regimen aims to control bacterial infection, minimize gingival inflammation, and accelerate soft tissue wound healing following scaling and root planing or periodontal surgery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chlorhexidine + perioscience.